The U.S. Food and Drug Administration has approved secukinumab for the treatment of moderate to severe plaque psoriasis in adults.
The injectable interleukin-17A inhibitor is indicated for...
The findings of a new study challenge the importance of anti–double stranded DNA antibodies as a diagnostic hallmark for lupus.
The assessment of different anti–double stranded DNA (dsDNA) antibody...
The findings of a new study challenge the importance of anti–double stranded DNA antibodies as a diagnostic hallmark for lupus.
The assessment of different anti–double stranded DNA (dsDNA) antibody...
New guidelines on nail psoriasis address four clinical manifestations of the disease. The recommendations by the Medical Board of the National Psorias... More »
Patients with psoriatic arthritis and psoriasis report having a better response to etanercept the earlier they are treated, according to a post hoc analysis of the PRESTA trial.
Patients with...
Patients with psoriatic arthritis and psoriasis report having a better response to etanercept the earlier they are treated, according to a post hoc analysis of the PRESTA trial.
Patients with...
Maintaining clinical remission with half-dose etanercept is possible for many rheumatoid arthritis patients, according to a single-center, prospective cohort study.
Over 80% of rheumatoid arthritis...
Eczema in adulthood is directly associated with an increase in incidence of injuries that cause physical limitations, particularly fracture, bone, and... More »
Eczema in adulthood is directly associated with an increase in incidence of injuries that cause physical limitations, particularly fracture, bone, and... More »
Adalimumab alleviated symptoms and improved physical functions in certain patients with active nonpsoriatic peripheral spondyloarthritis in the first ... More »